EcoDrugPlus

Adrenoceptor Alpha 2c

Ensembl ID : ENSECRG00000001933
Gene Symbol: ADRA2C
3 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSECRG00000003414
Gene Symbol: ADRB1
3 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSECRG00000013059
Gene Symbol: ADRB2
3 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSECRG00000000268
Gene Symbol: ADRB3
3 Cross references
218 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSECRG00000004767
Gene Symbol: LOC114654938
2 Cross references
429 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSECRG00000004756
Gene Symbol: LOC114654914
2 Cross references
429 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSECRG00000004728
Gene Symbol: LOC114654919
2 Cross references
429 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSECRG00000023036
Gene Symbol: GAA
3 Cross references
233 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSECRG00000007763
Gene Symbol: LOC114655441
3 Cross references
202 Possible Orthologues:

Alpha-2a Adrenergic Receptor-Like

Ensembl ID : ENSECRG00000000205
Gene Symbol: LOC114648916
3 Cross references
222 Possible Orthologues:

Amine Oxidase [Flavin-Containing] B-Like

Ensembl ID : ENSECRG00000016245
Gene Symbol: LOC114663148
2 Cross references
148 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSECRG00000005274
Gene Symbol: AOC1
3 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).